Handelsinvest Investeringsforvaltning »

Apellis Pharmaceuticals shares owned by Handelsinvest Investeringsforvaltning

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Handelsinvest Investeringsforvaltning from 13F filings

Historical chart of Handelsinvest Investeringsforvaltning investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Handelsinvest Investeringsforvaltning consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Handelsinvest Investeringsforvaltning

Quarter filed Position value Share count Share price at filing
2024-03-31 $159k 2.7k 58.95
2023-12-31 $245k 4.1k 59.80

More positions owned by Handelsinvest Investeringsforvaltning

Microsoft Corp Common Stock (MSFT)
NVIDIA Corp Common Stock (NVDA)
Apple Common Stock (AAPL)
Amazon.com Common Stock (AMZN)
Alphabet Common Stock (GOOGL)
Meta Platforms Common Stock (META)
JPMorgan Chase & Co Common Stock (JPM)
Eli Lilly & Co Common Stock (LLY)
Broadcom Common Stock (AVGO)
Visa Common Stock (V)
Mastercard Common Stock (MA)
UnitedHealth Group Common Stock (UNH)
Procter & Gamble Co/The Common Stock (PG)
Merck & Co Common Stock (MRK)
Alphabet Common Stock (GOOG)

View all positions for Handelsinvest Investeringsforvaltning

Top funds holding Apellis Pharmaceuticals

Wellington Management Company
EcoR1 Capital
venBio Select Advisor
Vanguard Group
Jennison Associates
Octagon Capital Advisors
Jpmorgan Chase & Co
T. Rowe Price Associates
Assenagon Asset Management
Logos Global Management
Boxer Capital
Artal Group
Citadel Advisors
Caption Management
Norges Bank Investment Management

View all funds holding Apellis Pharmaceuticals